000 01210 a2200313 4500
005 20250514073822.0
264 0 _c20040305
008 200403s 0 0 eng d
022 _a1433-7851
024 7 _a10.1002/anie.200351136
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHergenrother, Paul J
245 0 0 _aAn abiotic strategy for the enantioselective synthesis of erythromycin B.
_h[electronic resource]
260 _bAngewandte Chemie (International ed. in English)
_cJul 2003
300 _a3278-81 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnti-Bacterial Agents
_xchemical synthesis
650 0 4 _aCyclization
650 0 4 _aErythromycin
_xanalogs & derivatives
650 0 4 _aGlycosylation
650 0 4 _aMacrolides
_xchemical synthesis
650 0 4 _aStereoisomerism
700 1 _aHodgson, Anne
700 1 _aJudd, Andrew S
700 1 _aLee, Wen-Cherng
700 1 _aMartin, Stephen F
773 0 _tAngewandte Chemie (International ed. in English)
_gvol. 42
_gno. 28
_gp. 3278-81
856 4 0 _uhttps://doi.org/10.1002/anie.200351136
_zAvailable from publisher's website
999 _c12654098
_d12654098